V. Vávrová

1.3k total citations
39 papers, 690 citations indexed

About

V. Vávrová is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology and Nephrology. According to data from OpenAlex, V. Vávrová has authored 39 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 4 papers in Endocrinology and 3 papers in Nephrology. Recurrent topics in V. Vávrová's work include Cystic Fibrosis Research Advances (24 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (6 papers). V. Vávrová is often cited by papers focused on Cystic Fibrosis Research Advances (24 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (6 papers). V. Vávrová collaborates with scholars based in Czechia, Germany and United Kingdom. V. Vávrová's co-authors include Burkhard Tümmler, Richard Conway, Milan Maçek, K. De Boeck, G. Canny, Marijke Proesmans, Diana Bilton, Lena Hjelte, Anna Šedivá and H Kollberg and has published in prestigious journals such as The Journal of Pediatrics, Genomics and BMC Medical Research Methodology.

In The Last Decade

V. Vávrová

36 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Vávrová Czechia 14 542 108 77 67 52 39 690
A Rüdeberg Switzerland 10 623 1.1× 148 1.4× 113 1.5× 60 0.9× 48 0.9× 18 852
Donatello Salvatore Italy 18 752 1.4× 65 0.6× 72 0.9× 58 0.9× 82 1.6× 58 876
Satish Kumar India 11 252 0.5× 284 2.6× 140 1.8× 35 0.5× 96 1.8× 57 876
K Kawakami Japan 12 352 0.6× 84 0.8× 207 2.7× 204 3.0× 56 1.1× 26 709
Michelle Wood United Kingdom 12 215 0.4× 119 1.1× 56 0.7× 32 0.5× 29 0.6× 39 494
T. D. Brogan United Kingdom 11 175 0.3× 84 0.8× 51 0.7× 65 1.0× 77 1.5× 24 444
Weiying Chen China 14 79 0.1× 106 1.0× 100 1.3× 53 0.8× 107 2.1× 43 614
Marina Blanco Spain 12 522 1.0× 67 0.6× 107 1.4× 138 2.1× 35 0.7× 19 627
Holly R. Keir United Kingdom 16 709 1.3× 222 2.1× 199 2.6× 170 2.5× 43 0.8× 58 952
Fengming Ding China 11 143 0.3× 147 1.4× 39 0.5× 115 1.7× 20 0.4× 18 463

Countries citing papers authored by V. Vávrová

Since Specialization
Citations

This map shows the geographic impact of V. Vávrová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vávrová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vávrová more than expected).

Fields of papers citing papers by V. Vávrová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Vávrová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vávrová. The network helps show where V. Vávrová may publish in the future.

Co-authorship network of co-authors of V. Vávrová

This figure shows the co-authorship network connecting the top 25 collaborators of V. Vávrová. A scholar is included among the top collaborators of V. Vávrová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Vávrová. V. Vávrová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klimeš, Jiřı́, V. Vávrová, Veronika Skalická, et al.. (2016). Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study. The European Journal of Health Economics. 18(1). 73–82. 9 indexed citations
2.
Skalická, Veronika, V. Vávrová, D Zemková, et al.. (2012). PCR detection of Burkholderia cepacia complex as one of key factors to handle a long-term outbreak. Journal of Cystic Fibrosis. 11(5). 440–445. 13 indexed citations
3.
Piskáčková, T., M. Balaščaková, Marek Turnovec, et al.. (2012). Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations. Journal of Cystic Fibrosis. 12(5). 532–537. 16 indexed citations
4.
Boeck, K. De, et al.. (2012). Quality assessment of expert answers to lay questions about cystic fibrosis from various language zones in Europe: the ECORN-CF project. BMC Medical Research Methodology. 12(1). 11–11. 2 indexed citations
5.
Balaščaková, M., Veronika Skalická, T. Piskáčková, et al.. (2012). Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA. European Journal of Pediatrics. 171(8). 1223–1229. 27 indexed citations
6.
Koloušková, Stanislava, D. Zemková, Veronika Skalická, et al.. (2011). Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study. Journal of Pediatric Endocrinology and Metabolism. 24(7-8). 449–54. 33 indexed citations
7.
Bilton, Diana, G. Canny, Richard Conway, et al.. (2011). Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. Journal of Cystic Fibrosis. 10. S79–S81. 149 indexed citations
8.
Pressler, Tacjana, Richard Conway, Niels Høiby, et al.. (2011). Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. Journal of Cystic Fibrosis. 10. S75–S78. 116 indexed citations
9.
10.
Kotalová, Radana, et al.. (2008). Wilson disease as a cause of liver injury in cystic fibrosis. Journal of Cystic Fibrosis. 8(1). 63–65. 2 indexed citations
11.
Kotaška, Karel, et al.. (2008). Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Journal of Clinical Pharmacy and Therapeutics. 33(4). 409–417. 18 indexed citations
12.
Vávrová, V., et al.. (2007). Řízení výroby a nákupu.. 2 indexed citations
13.
Vávrová, V., et al.. (2006). Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clinical Immunology. 121(3). 350–357. 40 indexed citations
14.
Vankeerberghen, Anne, Olga Scudiero, K. De Boeck, et al.. (2005). Distribution of human β-defensin polymorphisms in various control and cystic fibrosis populations. Genomics. 85(5). 574–581. 30 indexed citations
15.
Skalická, Veronika, Karel Kotaška, Martin Chada, et al.. (2003). Serum alpha-glutathione S-transferase as a sensitive marker of hepatocellular damage in patients with cystic fibrosis. Physiological Research. 361–365. 12 indexed citations
16.
Šedivá, Anna, et al.. (1998). Antineutrophil Cytoplasmic Autoantibodies (ANCA) in Children with Cystic Fibrosis. Journal of Autoimmunity. 11(2). 185–190. 31 indexed citations
17.
Varon, Raymonda, Manfred Stuhrmann, Milan Maçek, et al.. (1995). Pancreatic insufficiency and pulmonary disease in German and Slavic cystic fibrosis patients with the R347P mutation. Human Mutation. 6(3). 219–225. 9 indexed citations
18.
Maçek, Milan, V. Vávrová, Manfred Stuhrmann, et al.. (1990). Frequency of the ΔF508 mutation and flanking marker haplotypes at the CF locus from 167 Czech families. Human Genetics. 85(4). 417–418. 6 indexed citations
19.
Frič, P, et al.. (1979). A peroral test of pancreatic insufficiency with 4-(N-acetyl-l-tyrosyl)aminobenzoic acid in children with cystic fibrosis. The Journal of Pediatrics. 94(6). 942–944. 7 indexed citations
20.
Vávrová, V., et al.. (1969). [pH, PCO2 and nonrespiratory component of the acid-base balance of the arterialized cutaneous blood in 97 healthy children from 3 months to 15 years of age].. PubMed. 25(10). 1121–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Rüdeberg Breakdown of academic impact, for papers by Donatello Salvatore Breakdown of academic impact, for papers by Satish Kumar Breakdown of academic impact, for papers by K Kawakami Breakdown of academic impact, for papers by Michelle Wood Breakdown of academic impact, for papers by T. D. Brogan Breakdown of academic impact, for papers by Weiying Chen Breakdown of academic impact, for papers by Marina Blanco Breakdown of academic impact, for papers by Holly R. Keir Breakdown of academic impact, for papers by Fengming Ding
Rankless by CCL
2026